http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012052834-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e2f78b23add0bcb5affdf7d1b9a54c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d5aaccf6e3488fc60933948cde0f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1d693733e6409a9eafceaef10a88104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_254466e6ed5cc66db460ff2ad0018dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d1dc2234977ac6d76601152decd128f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7ca54c9d3876f6d705f253aa0119374
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4a045f828e9eb5b70627d8a90c742e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_284e3114119779701c4de5fe5968ca58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ac3de5842420971f33c332eac5ddec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db96e35eb78f2c585d1088de0b55f6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37f93bb396d5d42033c44063d5d6b8d8
publicationDate 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012052834-A3
titleOfInvention Multiple unit particulate system comprising metoprolol succinate
abstract The invention provides extended release pharmaceutical compositions comprising metoprolol or a pharmaceutically acceptable salt thereof such as metoprolol succinate wherein the composition is in the form of multiple unit extended release pellets that are compressed into tablets. The extended release pellets of the invention comprise of water soluble or water swellable inert core, the drug layer and extended release polymer layer comprising atleast one water insoluble polymer. These extended release pellets are compressed into tablets such that dissolution profile of the extended release pellets remains substantially unaffected.
priorityDate 2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005008701-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010255093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009208570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010255105-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46908260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9800288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226710861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426056

Total number of triples: 37.